Evidence map›Paper›PMID 41505117›Full record

ArticleJAMA2026

Safe and Sufficient-Ibuprofen for Pediatric Musculoskeletal Injuries.

Jessica B Calihan, Tori N Sutherland, Scott E Hadland

Abstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in JAMA, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Jessica B CalihanDivision of Adolescent and Young Adult Medicine, Mass General Brigham for Children, Harvard Medical School, Boston, Massachusetts.
Tori N SutherlandDepartment of Anesthesiology and Critical Care, Children's Hospital of Philadelphia (CHOP), University of Pennsylvania Perelman School of Medicine, Philadelphia.
Scott E HadlandDivision of Adolescent and Young Adult Medicine, Mass General Brigham for Children, Harvard Medical School, Boston, Massachusetts.

Funding

The National Drug Abuse Treatment Clinical Trials NetworkUG1DA015831 · NIDA · YALE UNIVERSITY · PI Gail D'Onofrio, Roger D. Weiss · 2015 to 2026
$110.8M
The Cascade of Care for Medicaid-Enrolled Youth with Opioid Use DisorderR01DA057566 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI Scott Evan Hadland · 2022 to 2026
$2.9M
Adapting and Testing a Youth Overdose Prevention ToolkitR34DA062280 · NIDA · UNIVERSITY OF BRITISH COLUMBIA · PI FAST, DANYA, HADLAND, SCOTT EVAN · 2024 to 2024
$572k
Substance Use and Firearm Injuries among Medicaid-enrolled YouthK18DA059913 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI HADLAND, SCOTT EVAN · 2023 to 2023
$564k
The Adolescent Surgery Experience: Preoperative Anticipatory Guidance and Postoperative Opioid Misuse (POM)K23DA063939 · NIDA · CHILDREN'S HOSP OF PHILADELPHIA · PI Tori Sutherland · 2025 to 2026
$355k
NIDA NIH HHS K18 DA059913NIDA NIH HHS K23 DA063939NIDA NIH HHS R01 DA057566NIDA NIH HHS R34 DA062280NIDA NIH HHS UG1 DA015831
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41505117
PMCPMC12951067

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.